Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

NDAQ:APHA - Post Discussion

Aphria Inc. > CDN CANNABIS INVENTORY SOARS TO NEW HIGH! MORE PAIN AHEAD!
View:
Post by Humanist on Jul 08, 2020 10:37am

CDN CANNABIS INVENTORY SOARS TO NEW HIGH! MORE PAIN AHEAD!

Canadian cannabis inventory soars to new high, indicating more pain ahead for producers

Published july 8, 2020/ 10:25 am | By Matt Lamers

https://mjbizdaily.com/wp-content/uploads/2020/07/Canada-inventories-v-sales-v3.png

Federally licensed producers in Canada are stockpiling more cannabis than ever, new figures from the federal government Canada show, indicating that some producers are in store for more financial pain as the market looks for equilibrium.

Canadian cultivators and processors had amassed some 620,144 kilograms (1.4 million pounds) of unpackaged cannabis inventory as of April – defined as cannabis in stock that is not packaged for sale to consumers at the retail level.
 
In addition, some 85,014 kilograms of packaged inventory was being held by federal license holders, retailers and wholesalers in the same month – defined as cannabis in inventory that is packaged for sale to consumers.

It is a similar story for extracts, edibles and topicals, however Health Canada uses “packaged units” to measure those inventory levels.
For example, the Health Canada data shows over 9 million packaged units of cannabis extracts in April versus sales of a little over 1 million packaged units.


In the leadup to legalization in October 2018, the largest Canadian producers spent billions of dollars building up production capacity and on and acquisitions – moves criticized as a nod to stock market investors rather than an attempt to address actual consumer demand.
Much of that capacity was shown to be misplaced, despite a short-lived scarcity in the months following legalization.

Since the shortage abated, producers like Canopy Growth and Aurora Cannabis raced to slash costs and excess production, laid off thousands of workers and write down billions in inventory. Some are selling greenhouses for a fraction of their original cost.

Deeper industry-wide cuts might still be needed for the large producers to shed excess production, even as the industry continues to see impressive month-on-month retail sales growth.

Craig Wiggins, managing director of market researcher TheCannalysts, said “It’s plain old supply and demand. If you cannot sell what you’re making, it starts backing up and you will eventually have to write it down or destroy it if it doesn’t sell.”

“We’ve seen a cutting of capacity, but the capacity that they reduced to might still be optimistic,” said Wiggins.

“The total addressable market is growing. There’s no question about it,” he said. “But it’s not growing to the extent that it can absorb the unsalable product, so adjustments are coming.”

Brock University business professor Michael Armstrong says looming outdoor harvests this fall could also factor into inventories.
The amount of space licensed to grow cannabis outdoors now exceeds indoor and greenhouse.


“The (production) bump next fall is probably going to be even larger (than 2019’s), so current indoor production plans should be taking into account that a surge is going to come from outdoor.”

Health Canada’s cannabis market data can be found here.
Matt Lamers is Marijuana Business Daily’s international editor, based near Toronto. He can be reached at mattl@mjbizdaily.com.
Comment by Buoyohbuoy on Jul 08, 2020 10:57am
Hmm who said this very same thing about Aphria. Like I said they have a warehouse full of unsellable product and are moyhballing phase 4. You don't have to like it but its true.
Comment by Medicalcan on Jul 08, 2020 11:10am
Phase 4 was Aphria one which they have actually expanded by moving extraction from ECOE into Aphria one because ECOE was waiting for licenses. Stop spreading fud!
Comment by Mikelitoris2344 on Jul 08, 2020 10:58am
This post has been removed in accordance with Community Policy
Comment by Savage97 on Jul 08, 2020 11:11am
This is actually great news for Aphria as most of its competitors will not be able to sell product outside of Canada and/or compete with their lowest cost prices for quality flower.  GLTA
Comment by Buoyohbuoy on Jul 08, 2020 11:17am
Absolutely wrong , competition will be selling product at any price point just to get rid of it and create cash flow.
Comment by Medicalcan on Jul 08, 2020 11:22am
Do you have any clue to what aphria's business model is and that they are a CPG company focused on branding and it has been proven people don't want cheap garbage weed?
Comment by Buoyohbuoy on Jul 08, 2020 11:26am
Do you have any clue about "price point" Cannabis is no different than alcohol put something on sale that's similar people but it
Comment by Medicalcan on Jul 08, 2020 11:34am
wrong because compare smirnoff to grey goose you could take 90% off smirnoff I'm still sticking with my grey goose. So sick and tired of people talking about dry flower as if it is only source of revenue it is a fraction. Proves again you have no clue to Aphria's business model where they view it as an ingredient! Do you have any clue as to how many products you can infuse with marijuana ...more  
Comment by Mikelitoris2344 on Jul 08, 2020 1:50pm
This post has been removed in accordance with Community Policy
Comment by wideopenthrottl on Jul 08, 2020 12:13pm
This post has been removed in accordance with Community Policy
Comment by Buoyohbuoy on Jul 08, 2020 12:20pm
How did INT work out for you WOT. LOL
Comment by Medicalcan on Jul 08, 2020 12:42pm
I'm sorry is that english?
Comment by Mikelitoris2344 on Jul 08, 2020 1:35pm
This post has been removed in accordance with Community Policy
Comment by wideopenthrottl on Jul 08, 2020 3:44pm
This post has been removed in accordance with Community Policy
Comment by wideopenthrottl on Jul 08, 2020 3:47pm
This post has been removed in accordance with Community Policy
Comment by ZipLokBaggies4U on Jul 08, 2020 12:40pm
That's what keeps us old longs here. But the Canadian government does everything in their authority to deny LP's any self promotion of brands. And the Ontario government has throttled sufficent supply via retail stores. Canabis never gets any respect, still regarded as the evil weed.
Comment by Mikelitoris2344 on Jul 08, 2020 11:34am
This post has been removed in accordance with Community Policy
Comment by ZipLokBaggies4U on Jul 08, 2020 12:41pm
There is still no real demand for Cannabis in Germany, or Italy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities